Year |
Citation |
Score |
2016 |
Kambhampati M, Gittens J, Yadavilli S, Pai SB, McNeeley KM, Becher OJ, Packer RJ, Bellamkonda R, Fernandes R, Nazarian J. HG-64DEVELOPMENT OF IN VIVO DRUG AND GENE DELIVERY SYSTEMS TO BRAIN TUMOR USING LIPOSOMAL NANOCARRIERS Neuro-Oncology. 18: iii62.3-iii62. DOI: 10.1093/Neuonc/Now073.60 |
0.596 |
|
2014 |
Kambhampati M, Yadavilli S, McNeeley KM, Pai SB, Yu Q, Bellamkonda R, Fernandes R, Packer RJ, Nazarian J. NI-44 * LIPOSOMAL NANOPARTICLES FOR TARGETING AND IMAGING OF PEDIATRIC BRAIN TUMORS Neuro-Oncology. 16: v147-v148. DOI: 10.1093/Neuonc/Nou264.42 |
0.657 |
|
2013 |
McNeeley K, Lyon JG, Bellamkonda R. Biomaterial strategies to modulate cancer Biomaterials For Cancer Therapeutics: Diagnosis, Prevention and Therapy. 417-444. DOI: 10.1533/9780857096760.4.417 |
0.572 |
|
2011 |
Loomis K, McNeeley K, Bellamkonda RV. Nanoparticles with targeting, triggered release, and imaging functionality for cancer applications Soft Matter. 7: 839-856. DOI: 10.1039/C0Sm00534G |
0.612 |
|
2009 |
Karathanasis E, Chan L, Karumbaiah L, McNeeley K, D'Orsi CJ, Annapragada AV, Sechopoulos I, Bellamkonda RV. Tumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers. Plos One. 4: e5843. PMID 19513111 DOI: 10.1371/Journal.Pone.0005843 |
0.58 |
|
2009 |
McNeeley KM, Karathanasis E, Annapragada AV, Bellamkonda RV. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors. Biomaterials. 30: 3986-95. PMID 19427688 DOI: 10.1016/J.Biomaterials.2009.04.012 |
0.627 |
|
2009 |
Karathanasis E, Suryanarayanan S, Balusu SR, McNeeley K, Sechopoulos I, Karellas A, Annapragada AV, Bellamkonda RV. Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography. Radiology. 250: 398-406. PMID 19188313 DOI: 10.1148/Radiol.2502080801 |
0.572 |
|
2007 |
McNeeley KM, Annapragada A, Bellamkonda RV. Decreased circulation time offsets increased efficacy of PEGylated nanocarriers targeting folate receptors of glioma Nanotechnology. 18. DOI: 10.1088/0957-4484/18/38/385101 |
0.562 |
|
2007 |
Karathanasis E, McNeeley K, Agarwal A, Annapragada A, Bellamkonda R. MR Trackable, Chemotherapeutic Nanoparticles for Patient Specific Glioma Therapy Microscopy and Microanalysis. 13. DOI: 10.1017/S1431927607074909 |
0.65 |
|
Show low-probability matches. |